1.A Study of CNP520 Versus Placebo in Participants
at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease (Generation S2) ( Sponsor: Novartis Pharmaceuticals)
This study is
now available for enrollment. Call Carol or Leah K for more information at 518-785-1000 or 518-389-6876.
Click here for more information from ClinicalTrials.gov
Click here for the Generations Study Facebook Page
Click here for more information about the Generation Study:
2. A Study of CAD106 AND CNP520 Versus Placebo
in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease (Generation S1) ( Sponsor: Novartis Pharmaceuticals)
This study is
now available for enrollment. Call Carol or Leah K for more information at 518-785-1000 or 518-389-6876.
Click here for more information from ClinicalTrials.gov
Click here for the Generations Study Facebook Page
Click here for more information about the Generation Study:
3. A Study to Evaluate the Efficacy and Safety
of RO7105705 in Patients with Prodromal to Mild Alzheimer's Disease Sponsor: Genentech, Inc
This study is available
for enrollment. Call Carol for more information at 518-785-1000.
Click here for more information from ClinicalTrials.gov:
|